Pharmabiz16m
Telangana DCA raids de-addiction centre at Hanumakonda & seizes huge quantities of drugs stocked without licence
Telangana DCA raids de-addiction centre at Hanumakonda & seizes huge quantities of drugs stocked without licence: Peethaambaran Kunnathoor, Chennai Thursday, January 23, 2025, 08: ...
Pharmabiz16m
Indian pharma exudes confidence to sustain US market presence under President Trump’s regime
Indian pharma exudes confidence to sustain US market presence under President Trump’s regime: Nandita Vijayasimha, Bengaluru Thursday, January 23, 2025, 08:00 Hrs [IST] Indian p ...
Pharmabiz16m
NPPA calls for price data on diagnostic agent iohexol following DoP's review order
NPPA calls for price data on diagnostic agent iohexol following DoP's review order: Gireesh Babu, New Delhi Thursday, January 23, 2025, 08:00 Hrs [IST] The National Pharmaceutical ...
Pharmabiz16m
ADMI expects tax incentives, regulatory reforms & rationalisation of GST from Union Budget 2025
ADMI expects tax incentives, regulatory reforms & rationalisation of GST from Union Budget 2025: Our Bureau, New Delhi Thursday, January 23, 2025, 08:00 Hrs [IST] The medical devi ...
Pharmabiz16m
CDSCO seeks urgent industry inputs on regulatory challenges and innovation in pharma
CDSCO seeks urgent industry inputs on regulatory challenges and innovation in pharma: Shardul Nautiyal, Mumbai Thursday, January 23, 2025, 08:00 Hrs [IST] The Central Drugs Standa ...
Pharmabiz14h
Poxel receives Chinese patent for use of Imeglimin for type-2 diabetic patients with renal impairment
Poxel receives Chinese patent for use of Imeglimin for type-2 diabetic patients with renal impairment: Lyon, France Wednesday, January 22, 2025, 18:00 Hrs [IST] Poxel SA, a clinic ...
Pharmabiz18h
Strides Pharma debuts with a stellar ESG rating of 76/100 in the S&P Global’s Corporate Sustainability Assessment
Strides Pharma debuts with a stellar ESG rating of 76/100 in the S&P Global’s Corporate Sustainability Assessment: Our Bureau, Bengaluru Wednesday, January 22, 2025, 13:40 Hrs [ ...
Pharmabiz19h
Nanobiotix begins patient dosing in new randomized phase 2 study of JNJ-1900 for patients with stage 3 unresectable NSCLC
Nanobiotix begins patient dosing in new randomized phase 2 study of JNJ-1900 for patients with stage 3 unresectable NSCLC: Paris Wednesday, January 22, 2025, 13:00 Hrs [IST] Nanob ...
Pharmabiz21h
Pharming to nominate Fabrice Chouraqui as new executive director and chief executive officer
Pharming to nominate Fabrice Chouraqui as new executive director and chief executive officer: Leiden, the Netherlands ...
Pharmabiz17h
Ascletis announces positive results from US phase Ia SAD study of small molecule oral GLP-1R agonist ASC30 in patients with obesity
Ascletis announces positive results from US phase Ia SAD study of small molecule oral GLP-1R agonist ASC30 in patients with obesity: Hong Kong, China Wednesday, January 22, 2025, ...
Pharmabiz18h
Junshi Biosciences enters distribution and marketing partnership with LEO Pharma for toripalimab in Europe
Junshi Biosciences enters distribution and marketing partnership with LEO Pharma for toripalimab in Europe: Shanghai, China Wednesday, January 22, 2025, 14:00 Hrs [IST] Shanghai J ...
Pharmabiz15h
DKSH expands exclusive partnership with Hygiena, a global leader in food safety and health diagnostics, to include Malaysia
DKSH expands exclusive partnership with Hygiena, a global leader in food safety and health diagnostics, to include Malaysia: Camarillo, California Wednesday, January 22, 2025, 17: ...